Pfizer vaccine
-
How Moderna and Pfizer vaccines could rapidly update their vaccines for Omicron
Deborah Fuller, The Conversation
-
Top 10 Covid updates: Prior infection cuts risk of getting affected for up to 10 months, shows study
Scroll Staff
-
Covid-19: UK clears use of Pfizer vaccine among children aged 12-15
Scroll Staff
-
Covid: Pfizer vaccine produces nearly six times fewer antibodies against delta variant, shows study
Scroll Staff
-
Mixing and matching Covid-19 vaccines may not be such a bad idea after all
Fiona Russell, The Conversation John Hart, The Conversation
-
As Pfizer seeks approval in India, Kejriwal calls for swift procurement of children’s vaccine
Scroll Staff
-
Coronavirus: US authorises Pfizer vaccine for use in 12-15 year olds
Scroll Staff
-
India is producing less than half of the 1 crore Covid-19 vaccine doses it needs every day
Govindraj Ethiraj, IndiaSpend.com
-
The deaths of 30 Pfizer vaccine recipients in Norway show it is stimulating an immune response
Nathan Bartlett, The Conversation
-
Why the International Statistic of the Year is 332
Liberty Vittert, The Conversation
-
BioNTech says it can adapt its coronavirus vaccine in six weeks to tackle new strain
Scroll Staff
-
In the world of blatant national interest, refrigeration isn’t the only hurdle for a mass vaccine
Max Lawson
-
Two people experiencing an allergic reaction to the Pfizer vaccine is not a cause for panic
Nicholas Wood, The Conversation Ketaki Sharma, The Conversation
-
As Covid-19 vaccines are ready to take off, here’s how Mumbai airport is gearing up for its delivery
Niharika Sharma, qz.com
-
Coronavirus: Pfizer’s vaccine offers strong protection after first dose, says US drug regulator
Scroll Staff
-
Covid-19: Does it make sense to vaccinate India’s entire population?
Manavi Kapur, qz.com
-
Covid-19 vaccines are being developed in a record time. Is this reason to be wary?
Mark Toshner, The Conversation
-
How do Pfizer and Moderna vaccines work? And why do they need to be kept so cold?
Sanjay Mishra, The Conversation
-
Pfizer’s Covid-19 vaccine 95% effective in phase-3 study, says company
Scroll Staff
-
India working on strategy to procure Pfizer vaccine despite cold storage challenges, says Centre
Scroll Staff